A citation-based method for searching scientific literature

Federica Zito Marino, Greta Alì, Francesco Facchinetti, Luisella Righi, Gabriella Fontanini, Giulio Rossi, Renato Franco. Expert Rev Anticancer Ther 2021
Times Cited: 4







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.
Robin Guo, Lynne D Berry, Dara L Aisner, Jamie Sheren, Theresa Boyle, Paul A Bunn, Bruce E Johnson, David J Kwiatkowski, Alexander Drilon, Lynette M Sholl,[...]. J Thorac Oncol 2019
61
50

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial.
Alexander Drilon, Natasha Rekhtman, Maria Arcila, Lu Wang, Andy Ni, Melanie Albano, Martine Van Voorthuysen, Romel Somwar, Roger S Smith, Joseph Montecalvo,[...]. Lancet Oncol 2016
288
50

Molecular characterization of cancers with NTRK gene fusions.
Zoran Gatalica, Joanne Xiu, Jeffrey Swensen, Semir Vranic. Mod Pathol 2019
245
50

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials.
David S Hong, Steven G DuBois, Shivaani Kummar, Anna F Farago, Catherine M Albert, Kristoffer S Rohrberg, Cornelis M van Tilburg, Ramamoorthy Nagasubramanian, Jordan D Berlin, Noah Federman,[...]. Lancet Oncol 2020
336
50

The MLL recombinome of acute leukemias in 2017.
C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, R Sutton, N C Venn, M Emerenciano, M S Pombo-de-Oliveira,[...]. Leukemia 2018
353
25


Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
Richard Aplenc, Soheil Meshinchi, Lillian Sung, Todd Alonzo, John Choi, Brian Fisher, Robert Gerbing, Betsy Hirsch, Terzah Horton, Samir Kahwash,[...]. Haematologica 2020
56
25

Molecular Analysis of Gene Fusions in Bone and Soft Tissue Tumors by Anchored Multiplex PCR-Based Targeted Next-Generation Sequencing.
Suk Wai Lam, Anne-Marie Cleton-Jansen, Arjen H G Cleven, Dina Ruano, Tom van Wezel, Karoly Szuhai, Judith V M G Bovée. J Mol Diagn 2018
61
25

Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy.
Caitlin W Elgarten, Richard Aplenc. Curr Opin Pediatr 2020
38
25

Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies.
Borahm Kim, Hyeonah Lee, Saeam Shin, Seung-Tae Lee, Jong Rak Choi. J Mol Diagn 2019
19
25

FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature.
Min Jin Kim, Sun Young Cho, Myeong-Hee Kim, Jae Jin Lee, So Young Kang, Eun Hae Cho, Jungwon Huh, Hwi-Joong Yoon, Tae Sung Park, Woo-In Lee,[...]. Cancer Genet Cytogenet 2010
39
25

Cryptic translocation of PML/RARA on 17q. A rare event in acute promyelocytic leukemia.
Alfonso Zaccaria, Anna Valenti, Mila Toschi, Marzia Salvucci, Raffaella Cipriani, Emanuela Ottaviani, Giovanni Martinelli. Cancer Genet Cytogenet 2002
20
25


Narrative review of molecular pathways of kinase fusions and diagnostic approaches for their detection in non-small cell lung carcinomas.
Matthias S Matter, Obinna Chijioke, Spasenija Savic, Lukas Bubendorf. Transl Lung Cancer Res 2020
11
25

Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation.
Carina Heydt, Christina B Wölwer, Oscar Velazquez Camacho, Svenja Wagener-Ryczek, Roberto Pappesch, Janna Siemanowski, Jan Rehker, Florian Haller, Abbas Agaimy, Karl Worm,[...]. BMC Med Genomics 2021
25
25

Comparison of ALK detection by FISH, IHC and NGS to predict benefit from crizotinib in advanced non-small-cell lung cancer.
Chen Lin, Xun Shi, Shao Yang, Jun Zhao, Qiong He, Ying Jin, Xinmin Yu. Lung Cancer 2019
50
25

Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.
Christina I Selinger, Bob T Li, Nick Pavlakis, Matthew Links, Anthony J Gill, Adrian Lee, Stephen Clarke, Thang N Tran, Trina Lum, Po Y Yip,[...]. Histopathology 2017
39
25

Immunocytochemistry for predictive biomarker testing in lung cancer cytology.
Deepali Jain, Aruna Nambirajan, Alain Borczuk, Gang Chen, Yuko Minami, Andre L Moreira, Noriko Motoi, Mauro Papotti, Natasha Rekhtman, Prudence A Russell,[...]. Cancer Cytopathol 2019
48
25

Outcomes According to ALK Status Determined by Central IHC or FISH in Patients with ALK-Positive NSCLC Enrolled in the Phase III ALEX Study.
Tony Mok, Solange Peters, D Ross Camidge, Johannes Noé, Shirish Gadgeel, Sai-Hong Ignatius Ou, Dong-Wan Kim, Krzysztof Konopa, Emanuela Pozzi, Ting Liu,[...]. J Thorac Oncol 2020
13
25

ALK-rearrangement in non-small-cell lung cancer (NSCLC).
Xue Du, Yun Shao, Hai-Feng Qin, Yan-Hong Tai, Hong-Jun Gao. Thorac Cancer 2018
97
25

The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS.
Daisy Wing-Sze Wong, Elaine Lai-Han Leung, Kimpton Kam-Ting So, Issan Yee-San Tam, Alan Dart-Loon Sihoe, Lik-Cheung Cheng, Kwok-Keung Ho, Joseph Siu-Kie Au, Lap-Ping Chung, Maria Pik Wong. Cancer 2009
555
25

Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion.
Ji-Youn Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Han Yong Choi, So Young Kang, Yoon-La Choi, Ghee Young Kwon. J Clin Pathol 2016
12
25


Targeting molecular addictions in cancer.
I Vivanco. Br J Cancer 2014
30
25

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.
Erik Thunnissen, Timothy Craig Allen, Julien Adam, Dara L Aisner, Mary Beth Beasley, Alain C Borczuk, Philip T Cagle, Vera Luiza Capelozzi, Wendy Cooper, Lida P Hariri,[...]. Arch Pathol Lab Med 2018
55
25

Identifying and targeting ROS1 gene fusions in non-small cell lung cancer.
Kurtis D Davies, Anh T Le, Mariana F Theodoro, Margaret C Skokan, Dara L Aisner, Eamon M Berge, Luigi M Terracciano, Federico Cappuzzo, Matteo Incarbone, Massimo Roncalli,[...]. Clin Cancer Res 2012
302
25

Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review.
Rossella Bruno, Gabriella Fontanini. Diagnostics (Basel) 2020
44
25

Next-Generation Sequencing in Tumor Diagnosis and Treatment.
Dario de Biase, Matteo Fassan, Umberto Malapelle. Diagnostics (Basel) 2020
6
25

NTRK fusions in lung cancer: From biology to therapy.
Guilherme Harada, Fernando C Santini, Clare Wilhelm, Alexander Drilon. Lung Cancer 2021
8
25

5'/ 3' imbalance strategy to detect ALK fusion genes in circulating tumor RNA from patients with non-small cell lung cancer.
Yongqing Tong, Zhijun Zhao, Bei Liu, Anyu Bao, Hongyun Zheng, Jian Gu, Mary McGrath, Ying Xia, Bihua Tan, Chunhua Song,[...]. J Exp Clin Cancer Res 2018
19
25

ALK FISH patterns and the detection of ALK fusions by next generation sequencing in lung adenocarcinoma.
Sanja Dacic, Liza C Villaruz, Shira Abberbock, Alyssa Mahaffey, Pimpin Incharoen, Marina N Nikiforova. Oncotarget 2016
45
25

Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non-Small Cell Lung Cancer.
Richard A Blidner, Brian C Haynes, Stephen Hyter, Sarah Schmitt, Ziyan Y Pessetto, Andrew K Godwin, Dan Su, Patrick Hurban, Léon C van Kempen, Maria L Aguirre,[...]. J Mol Diagn 2019
10
25

Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.
Weihua Li, Lei Guo, Yutao Liu, Lin Dong, Lin Yang, Li Chen, Kaihua Liu, Yang Shao, Jianming Ying. J Thorac Oncol 2021
34
25

Diagnosis of fusion genes using targeted RNA sequencing.
Erin E Heyer, Ira W Deveson, Danson Wooi, Christina I Selinger, Ruth J Lyons, Vanessa M Hayes, Sandra A O'Toole, Mandy L Ballinger, Devinder Gill, David M Thomas,[...]. Nat Commun 2019
73
25

Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Danielle Cohen, Liesbeth M Hondelink, Nienke Solleveld-Westerink, Sandra M Uljee, Dina Ruano, Anne-Marie Cleton-Jansen, Jan H von der Thüsen, S Rajen S Ramai, Pieter E Postmus, Jacob F Graadt van Roggen,[...]. J Thorac Oncol 2020
42
25

Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
David R Spigel, Thomas J Ervin, Rodryg A Ramlau, Davey B Daniel, Jerome H Goldschmidt, George R Blumenschein, Maciej J Krzakowski, Gilles Robinet, Benoit Godbert, Fabrice Barlesi,[...]. J Clin Oncol 2013
374
25

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.
Young Seok Ju, Won-Chul Lee, Jong-Yeon Shin, Seungbok Lee, Thomas Bleazard, Jae-Kyung Won, Young Tae Kim, Jong-Il Kim, Jin-Hyoung Kang, Jeong-Sun Seo. Genome Res 2012
350
25

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer.
Marina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, Maya Ilouze, Addie Dvir, Theresa Boyle, Murry Wynes, Vincent A Miller, Doron Lipson, Gary A Palmer,[...]. Oncologist 2015
118
25



Deep RNA Sequencing Revealed Fusion Junctional Heterogeneity May Predict Crizotinib Treatment Efficacy in ALK-Rearranged NSCLC.
Zhengbo Song, Shifeng Lian, Silvia Mak, Maggie Zi-Ying Chow, Chunwei Xu, Wenxian Wang, Hoi Yee Keung, Chenyu Lu, Firaol Tamiru Kebede, Yanqiu Gao,[...]. J Thorac Oncol 2022
6
25

Dramatic Response to Crizotinib in a Patient with Lung Cancer Positive for an HLA-DRB1-MET Gene Fusion.
Kurtis D Davies, Terry L Ng, Adriana Estrada-Bernal, Anh T Le, Peter R Ennever, D Ross Camidge, Robert C Doebele, Dara L Aisner. JCO Precis Oncol 2017
44
25

A single-tube multiplexed assay for detecting ALK, ROS1, and RET fusions in lung cancer.
Maruja E Lira, Yoon-La Choi, Sun Min Lim, Shibing Deng, Donghui Huang, Mark Ozeck, Joungho Han, Ji Yun Jeong, Hyo Sup Shim, Byoung Chul Cho,[...]. J Mol Diagn 2014
87
25

RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer.
Teodora Radonic, W R R Geurts-Giele, Kris G Samsom, Guido M J M Roemen, Jan H von der Thüsen, Erik Thunnissen, Isabelle C Meijssen, Hein F B M Sleddens, Winand N M Dinjens, Mirjam C Boelens,[...]. J Thorac Oncol 2021
18
25

RET Gene Fusions in Malignancies of the Thyroid and Other Tissues.
Massimo Santoro, Marialuisa Moccia, Giorgia Federico, Francesca Carlomagno. Genes (Basel) 2020
39
25

Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approaches.
Julie A Vendrell, Sylvie Taviaux, Benoît Béganton, Sylvain Godreuil, Patricia Audran, David Grand, Estelle Clermont, Isabelle Serre, Vanessa Szablewski, Peter Coopman,[...]. Sci Rep 2017
67
25


Molecular mechanisms and pathobiology of oncogenic fusion transcripts in epithelial tumors.
Musaffe Tuna, Christopher I Amos, Gordon B Mills. Oncotarget 2019
15
25


Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.
Chiara Colato, Caterina Vicentini, Silvia Cantara, Serena Pedron, Paolo Brazzarola, Ivo Marchetti, Giancarlo Di Coscio, Marco Chilosi, Matteo Brunelli, Furio Pacini,[...]. Eur J Endocrinol 2015
7
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.